Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The EGFR polymorphism rs884419 is associated with freedom from recurrence in patients with resected prostate cancer.

The Journal of urology - 1 May 2010

Perez Carmen A, Chen Heidi, Shyr Yu, Courtney Regina, Zheng Wei, Cai Qiuyin, Hwang Misun, Jaboin Jerry, Schleicher Stephen, Moretti Luigi, Wills Marcia, Smith Joseph A, Lu Bo

Abstract excerpt

PURPOSE: Prognostic biomarkers are needed to optimize treatment decisions for prostate cancer. Single nucleotide polymorphisms participate in the individual genetic background modulating risk and clinical outcomes of cancer. We tested whether EGFR polymorphisms are associated with prostate cancer clinical outcomes. MATERIALS AND METHODS: The study population consisted of 212 patients with clinically localized...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Recurrence, Local

Share to Prognosis

Share to Proportional Hazards Models

Share to Prostatectomy

Share to Prostatic Neoplasms

Share to Survival Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 20303520
DOI: 10.1016/j.juro.2009.12.098
PMCID: PMC4165525

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The EGFR polymorphism rs884419 is associated with freedom from recurrence in patients with resected prostate cancer.PMID 20303520Read ↗

Improved prediction of biochemical recurrence after radical prostatectomy by genetic polymorphisms.Semantic proximity Read ↗

Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomy.Semantic proximity Read ↗

Genome-wide detection of allelic genetic variation to predict biochemical recurrence after radical prostatectomy among prostate cancer patients using an exome SNP chip.Semantic proximity Read ↗

Genetic predisposition to early recurrence in clinically localized prostate cancer.Semantic proximity Read ↗

The matrix metalloproteinase-7 polymorphism rs10895304 is associated with increased recurrence risk in patients with clinically localized prostate cancer.Semantic proximity Read ↗

Prognostic Value of Prostaglandin-endoperoxide Synthase 2 Polymorphisms in Prostate Cancer Recurrence after Radical Prostatectomy.Semantic proximity Read ↗

An MGMT Allelic Variant Can Affect Biochemical Relapse in Prostate Cancer Patients.Semantic proximity Read ↗

Genetic variants in RhoA and ROCK1 genes are associated with the development, progression and prognosis of prostate cancer.Semantic proximity Read ↗

Association of genetic variants in VEGF-A with clinical recurrence in prostate cancer patients treated with definitive radiotherapy.Semantic proximity Read ↗

Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence.Semantic proximity Read ↗

Genetic variants in microRNAs and microRNA target sites predict biochemical recurrence after radical prostatectomy in localized prostate cancer.Semantic proximity Read ↗

Gene expression profiling predicts clinical outcome of prostate cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.